financetom
Business
financetom
/
Business
/
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Apr 25, 2024 7:01 AM

April 25 (Reuters) - GlaxoSmithKline sued

Pfizer ( PFE ) and BioNTech in Delaware federal court

on Thursday, accusing them of infringing GSK patents related to

messenger RNA (mRNA) technology in the companies' blockbuster

COVID-19 vaccines.

GSK said in the lawsuit that Pfizer ( PFE ) and BioNTech's Comirnaty

vaccines violate the company's patent rights in mRNA-vaccine

innovations developed "more than a decade before" the outbreak

of the COVID-19 pandemic.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved